CIMED Projektbidrag 2027-2029

I årets utlysning av CIMED projektbidrag inkom totalt 180 ansökningar, varav 86 juniora och 94 seniora ansökningar.
Följande personer har efter vetenskaplig granskning och beslut av CIMED:s styrelse tilldelats CIMED projektbidrag för perioden 2027–2029:


Junior:

  • Anastasios Charalampidis: ” Selective nerve root block versus sham injection in lumbar disc herniation: a quadruple-blinded randomized controlled trial (SELDISC)”
  • Anna Marseglia: ”Uncovering Biological Processes and Resilience Mechanisms in Vascular Cognitive Impairment and Dementia (VCID)”
  • Anne-Laure Faucon: ”TARGET-CKD: Optimizing cardio-renal-metabolic treatment targets to improve outcomes in chronic kidney disease”
  • Antonino Cassotta: ”Dissecting the myeloma-reactive TCR repertoire to develop predictive models of clinical response to T cell engager therapy”
  • Axel Wester: ”Chronic liver disease – risk stratification and pharmacotherapy”
  • Catarina Lindqvist: ”Nourishing the failing liver: nutrition support across the full spectrum of liver disease”
  • Erik von Seth: ”Strictures and malignancy in the biliary tree – improving prognosis in primary sclerosing cholangitis”
  • Gabriella Frisk: ”Kliniska studier av ”Point of care ultrasound” och behandling av malign ascites i palliativ vård”
  • Hannes Jansson: ”Förbättrad prognostisk bedömning och systematisk utvärdering av behandling vid kolangiokarcinom”
  • Jacob Andersson Emad: ”Improving triage of patients with joint and muscle pain in primary care with a new digital decision support tool.”
  • Jakob Theorell: ”Finding, understanding and treating autoimmune encephalitides”
  • Jens Magnusson: ”Treating liver fibrosis with engineered Scar-CAR macrophages”
  • Jonathan Grip: ”SEdation strategies for improved REcovery and NEurological outcomes in ICU patients treated for compromised airway: The SERENE-ICU trial”
  • Maarten van de Klundert: ”Improvement of clinical care of persons living with HIV through implementation of and advanced diagnostic tool of drug resistance minor viral variants in the HIV reservoir”
  • Maria Bragesjö: ”Metacognitive therapy as an alternative to exposure for PTSD: a clinical study of individual and group-based treatment in outpatient psychiatry”
  • Martin Sundström Rehal: ”A personalized medicine approach to recovery of muscle function after critical illness”
  • Metoboroghene Mowoe: ”A KRAS-Activated Intracellular Therapeutic Platform for Pancreatic Cancer”
  • Oskar Flygare: ”Effect of Augmenting Standard Care with Caring Text Messages for Suicide Prevention – A Randomized Clinical Trial”
  • Rosaleena Mohanty: ”Mapping the contribution of vascular brain health to neurodegenerative diseases”
  • Sandra Af Winklerfelt-Hammarberg: ”Metakognitiv terapi för depression och generaliserat ångestsyndrom i primärvården, jämförelse av två varianter av förmedlad behandling”
  • Yawen Fu: ”Translational development of a GMP-ready targeted All-in-one Delivery Vehicle (AiDV) to generate in vivo CAR-T against B-ALL”
  • Ying Shang: ”GLP-1 receptor agonists in metabolic dysfunction-associated steatotic liver disease: who to treat, for how long, and how safe is it?

Senior:

  • Christina Villard: ”Transplantation oncology- the role of liver transplantation in treating colorectal liver metastases and cholangiocarcinoma”
  • Daniel Ferreira: ”’FindDLB’ – Assessing Lewy body pathology and early neurodegeneration in vivo and translating findings into clinical practice in Dementia with Lewy Bodies”
  • Edvard Smith: ”Gene Editing of X-linked Agammaglobulinemia”
  • Emma Svennberg: ”Waiting on Atrial fibrillation Intervention Therapy (WAIT) Study”
  • Eric Westman: ”Precision medicine in Alzheimer’s disease to improve diagnostic accuracy and enable optimal selection of patients for treatment and prevention”
  • Fredrik Klevebro: ”Timing of Minimally Invasive Local Treatment After First Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma”
  • Hans-Gustaf Ljunggren: ”Korsreaktiv immunitet mot potentiellt hotande zoonotiska coronavirus efter SARS-CoV-2 mRNA vaccination hos friska individer och patienter med immunbrist”
  • Helen Kaipe: ”Immunsystemets roll vid havandeskapsförgiftning – signaler från moderkakan”
  • Ioanna Markaki: ”Pathway to improved care in Parkinson’s disease: A randomized trial on electroconvulsive therapy”
  • Isabelle Magalhaes: ”Identification of cytotoxic, persistent CAR T cells for ovarian cancer treatment”
  • Lars Olaf Cardell: ”Neoadjuvant anti-PD-1 prior to surgical tumour excision in patients with oral squamous cell carcinoma – tumour draining lymph nodes being the focus of interest”
  • Marcus Buggert: ”Development and functional evaluation of mRNA–LNP–mediated CAR T cells for B cell–driven disease”
  • Martin Jädersten: ”SAMHD1 as a targetable resistance factor in acute myeloid leukemia”
  • Peter Bergman: ”Förekomst och betydelse av autoantikroppar mot cytokiner vid svåra infektioner hos patienter med misstänkt immunbrist”
  • Petter Höglund: ”Etiology, pathogenesis and diagnostics of autoimmune neutropenia”
  • Roland Fiskesund: ”From Blood Bank to Immunotherapy: A Non-Expanded Pooled NK Cell Product for Rapid NK DLI in AML and High Risk MDS (RAPID NK = Rapid Allogeneic Pooled Immunotherapy Development – NK)”
  • Sandra Tamm: ”Förbättrad behandling av sömnstörningar inom psykiatrisk heldygnsvård: utveckling, implementering och utvärdering av psykologiska och farmakologiska interventioner”
  • Sara Gredmark Russ: ”Host Immunomodulation and Its Influence on TBE Risk and Outcomes: Foundations for Monoclonal Antibody Based Prophylaxis and Treatment”
  • Soo Aleman: ”Kliniska, immunologiska, virologiska och mikrobiom-relaterade faktorer vid svår postcovid”
  • Volen Ivanov: ”From Exclusion to Employment: Individual Placement and Support for Adults with Autism Spectrum Disorder”
  • Ylva Trolle Lagerros: ”Bibehålla muskelmassa vid GLP-1-analogbehandling: från cell till intervention”

Uppdaterad av:

Lena Berglin 2026-06-17